Sep 15, 2020 · The new combined company will operate under the name Adicet Bio, Inc. ... In connection with the closing of the merger, resTORbio effected a 7:1 ...

resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics.

resTORbio Inc is a clinical-stage biopharmaceutical company. It mainly focuses on the development and commercialization of novel therapeutics for the treatment ...

resTORbio, Inc., a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat aging-related ...

Sep 15, 2020 · The new combined company will operate under the name Adicet Bio, Inc. and will commence trading on the Nasdaq Global Market under the ticker ...

Sep 15, 2020 · Privately held Adicet Bio Inc. completed its all-stock merger with Boston-based resTORbio Inc. as the combined company aims to develop ...

Welcome to https://www.restorbio.com/ - resTORbio is an advanced clinical stage company, developing medicines to treat aging-related diseases and conditions ...

resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related ...

Adicet Bio, Inc. entered into a definitive merger agreement to acquire resTORbio, Inc. in a reverse merger transaction for approximately $170 million on ...

Sep 16, 2020 · Restorbio Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.